Neuromuscular function and plasma drug levels in pyridostigmine treatment of myasthenia gravis.

In 18 patients with generalised myasthenia treated with oral pyridostigmine, muscular strength, decrement of neuromuscular transmission in the trapezius muscle on repetitive accessory nerve stimulation, and pyridostigmine plasma level were measured repeatedly during 1-3 dosing intervals. Significant...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Neurol Neurosurg Psychiatry
Päätekijät:	Breyer-Pfaff, U, Schmezer, A, Maier, U, Brinkmann, A, Schumm, F
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMJ Publishing Group 1990
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1014211/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2166138/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/jnnp.53.6.502
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!